Menu
Zoeken English

Prognostic factors and course for successful clinical outcome quality of life and patients' perceived effect after a cognitive behavior therapy for chronic non-specific low back pain: A 12-months prospective study

Publicatie van Kenniscentrum Zorginnovatie
K. Verkerk, H.S. Miedema, P.A.J. Luijsterburg, A. Pool-Goudzwaard, M.W. Heymans, B.W. Koes, I. Ronchetti | Artikel | Publicatiedatum: 01 februari 2015
This study investigates the clinical course of and prognostic factors for quality of life (Short Form 36 items Health survey (SF-36)) and global perceived effect (GPE) in patients treated for chronic nonspecific low back pain at 5 and 12-months follow-up. Data from a prospective cohort (n ¼ 1760) of a rehabilitation center were used, where patients followed a 2-months cognitive behavior treatment. The outcome ‘improvement in quality of life (SF-36)’ was defined as a 10% increase in score on the SF-36 at follow-up compared with baseline. On the GPE scale, patients who indicated to be ‘much improved’ were coded as ‘clinically improved’. Multivariable logistic regression analysis included 23 baseline characteristics. At 5-months follow-up, scores on the SF-36 Mental Component Scale (SF-36; MCS) and the Physical Component Scale (SF-36; PCS) had increased from 46.6 (SD 10.3) to 50.4 (SD 9.8) and from 31.9 (SD 7.1) to 46.6 (SD 10.3), respectively. At 5-months follow-up, 53.0% of the patients reported clinical improvement (GPE) which increased to 60.3% at 12-months follow-up. The 10% improvement in quality of life (SF-36 MCS) at 5-months follow-up was associated with patient characteristics and psychological factors. At 5-months follow-up, the 10% improvement in quality of life (SF-36 PCS) and GPE was associated with patient characteristics, physical examination, work-related factors and psychological factors; for GPE, an association was also found with clinical status. At 12-months follow-up GPE was associated with patient characteristics, clinical status, physical examination and work-related factors. The next phase in this prognostic research is external validation of these results.

Auteur(s)

Betrokken bij deze publicatie

We gebruiken cookies voor analyse en marketing om de website te verbeteren.

Wijzig cookie-instellingen